Pancreatic cancer is an increasingly common cause of cancer mortality with a tight
correspondence between disease mortality and incidence. Furthermore, it is usually …

Research on obesity-and diabetes mellitus (DM)-related carcinogenesis has expanded
exponentially since these two diseases were recognized as important risk factors for …

Background Both activated tumor-infiltrating lymphocytes (TILs) and immune-suppressive
cells, such as regulatory T cells (Tregs), in the tumor microenvironment (TME) play an …

CAR T cell research in solid tumors often lacks spatiotemporal information and therefore,
there is a need for a molecular tomography to facilitate high-throughput preclinical …

Tumor-infiltrating immune cells and fibroblasts are significant components of the tumor
microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC), and they participate …

Pancreatic ductal adenocarcinoma (PDAC), a prominent cause of cancer deaths worldwide,
is a highly aggressive cancer most frequently detected at an advanced stage that limits …

Despite intensive research and progress in personalized medicine, pancreatic ductal
adenocarcinoma remains one of the deadliest cancer entities. Pancreatic duct‐like …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal
malignant diseases. The association of monocytes with worse outcomes has been …

Pancreatic ductal adenocarcinoma (PDAC) still presents with a dismal prognosis despite
intense research. Better understanding of cellular homeostasis could identify druggable …

Simple Summary This study investigated the role of aryl hydrocarbon receptor (AHR)
expression in pancreatic ductal adenocarcinoma patients' peripheral blood immune cells …